Clinical Trial Update: A Pilot Study of Buspirone for the Treatment of Anxiety in Youth with Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial of buspirone for anxiety in youth with autism spectrum disorders has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Autism Spectrum Disorder

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism Spectrum Disorder, Anxiety | Phase 2 | Status: WITHDRAWN